Benedikt Schoser Selected Research

Glycogen Storage Disease Type II (Pompe's Disease)

5/2022	Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease.
12/2021	Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial.
12/2021	[Home infusion therapy for Pompe disease: Recommendations for German-speaking countries].
12/2021	Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.
8/2021	The impact of interrupting enzyme replacement therapy in late-onset Pompe disease.
7/2021	STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa.
5/2021	Uptake of moss-derived human recombinant GAA in Gaa -/- mice.
4/2021	[Home infusion therapy for Pompe disease: Recommendations for German-speaking countries].
4/2020	Moss-Derived Human Recombinant GAA Provides an Optimized Enzyme Uptake in Differentiated Human Muscle Cells of Pompe Disease.
12/2019	A Systematic Review of the Health Economics of Pompe Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benedikt Schoser Research Topics

Disease

27	Glycogen Storage Disease Type II (Pompe's Disease) 05/2022 - 10/2008
19	Muscular Diseases (Myopathy) 10/2022 - 09/2008
19	Myotonic Dystrophy (Dystrophia Myotonica) 01/2021 - 08/2009
8	Muscle Weakness 01/2018 - 11/2011
7	Muscular Dystrophies (Muscular Dystrophy) 01/2020 - 06/2011
6	Myalgia 12/2021 - 08/2004
6	Cardiomyopathies (Cardiomyopathy) 09/2017 - 09/2008
5	Neuromuscular Diseases (Neuromuscular Disease) 07/2021 - 07/2019
4	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2022 - 06/2012
4	Pain (Aches) 01/2022 - 11/2017
4	Disease Progression 08/2021 - 11/2011
4	Myasthenia Gravis 01/2018 - 03/2009
4	Myofibrillar Myopathy 12/2012 - 07/2009
3	Atrophy 01/2022 - 01/2018
3	Myotonia 01/2022 - 01/2018
3	Sarcopenia 09/2021 - 01/2019
3	Ataxia (Dyssynergia) 01/2020 - 07/2013
3	Vacuolar myopathy 10/2019 - 11/2008
3	Cataract (Cataracts) 01/2018 - 04/2010
3	Fatigue 01/2018 - 11/2017
2	Headache (Headaches) 12/2021 - 05/2016
2	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 01/2020 - 01/2015
2	Sarcoglycanopathies 01/2020 - 06/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 12/2018
2	Rupture 07/2019 - 07/2019
2	Cognitive Dysfunction 01/2019 - 03/2017
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2019 - 11/2013
2	Type 2G Limb-Girdle Muscular Dystrophy 01/2018 - 09/2017
2	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 09/2017 - 05/2016
2	Nausea 05/2017 - 05/2016
2	Intellectual Disability (Idiocy) 03/2017 - 07/2013
2	Frontotemporal Dementia (Semantic Dementia) 01/2017 - 10/2010
2	Congenital Structural Myopathies (Centronuclear Myopathy) 02/2016 - 07/2015
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2015 - 01/2011
2	Acute Kidney Injury (Acute Renal Failure) 11/2014 - 12/2010
2	Rhabdomyolysis 11/2014 - 12/2010
2	Glycogen Storage Disease Type V (McArdle's Disease) 11/2014 - 12/2010
2	Myoglobinuria 11/2014 - 12/2010
2	Distal Myopathies (Distal Muscular Dystrophy) 08/2011 - 04/2010
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 04/2010 - 09/2008
1	Neuralgia (Stump Neuralgia) 01/2022
1	Polyneuropathies (Polyneuropathy) 01/2022
1	Spasm (Spasms) 01/2022
1	VEXAS syndrome 01/2022
1	Nasopharyngitis 12/2021
1	Stroke (Strokes) 12/2021
1	Myocardial Infarction 12/2021
1	Anaphylaxis (Anaphylactic Shock) 12/2021
1	Arthralgia (Joint Pain) 12/2021
1	Carcinogenesis 10/2021
1	Clinical Deterioration 08/2021
1	Restless Legs Syndrome (Restless Legs) 07/2021

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
14	AcidsIBA 05/2022 - 10/2008
12	human GAA protein (Myozyme)FDA Link 12/2021 - 10/2008
11	GlycogenIBA 05/2022 - 09/2008
9	Creatine Kinase (Creatine Phosphokinase)IBA 01/2019 - 08/2004
8	alpha-Glucosidases (Acid Maltase)IBA 05/2021 - 10/2008
7	EnzymesIBA 12/2021 - 10/2008
6	GlucosidasesIBA 05/2022 - 07/2012
6	AntibodiesIBA 01/2022 - 03/2012
6	Protein AggregatesIBA 01/2018 - 07/2009
5	RNA (Ribonucleic Acid)IBA 01/2018 - 08/2009
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2022 - 12/2018
3	Carrier Proteins (Binding Protein)IBA 10/2016 - 11/2011
3	DesminIBA 12/2012 - 09/2008
2	CalciumIBA 10/2022 - 07/2015
2	Insulin-Like Growth Factor I (IGF-1)IBA 09/2021 - 01/2021
2	prednylidene (Pred)IBA 08/2021 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2020 - 10/2009
2	Mitochondrial DNA (mtDNA)IBA 01/2020 - 01/2015
2	milk-derived factorIBA 08/2019 - 12/2018
2	Protein Kinases (Protein Kinase)IBA 10/2016 - 07/2012
2	Phosphorylases (Glucan Phosphorylase)IBA 11/2014 - 12/2010
2	AutoantibodiesIBA 06/2014 - 03/2012
2	polyglucosanIBA 12/2013 - 09/2008
1	Mitochondrial Permeability Transition PoreIBA 10/2022
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2022
1	propylene diquat (PDQ(+))IBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Methocarbamol (Robaxin)FDA LinkGeneric 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	Mexiletine (Mexitil)FDA LinkGeneric 01/2022
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	miglustat (Zavesca)FDA Link 12/2021
1	PlectinIBA 11/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	Insulin (Novolin)FDA Link 10/2021
1	acetylleucineIBA 07/2021
1	Protons (Proton)IBA 06/2021

Therapy/Procedure

15	Enzyme Replacement Therapy 05/2022 - 10/2008
15	Therapeutics 12/2021 - 10/2008
5	Activities of Daily Living (ADL) 01/2021 - 10/2013
2	Home Infusion Therapy 12/2021 - 04/2021
2	Lasers (Laser) 05/2013 - 12/2012
1	Muscle Denervation 09/2021
1	Drug Therapy (Chemotherapy) 07/2021